Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Radhika Gali"'
Autor:
Emma Rabinovich, Kith Pradhan, Iffath Islam, Helen Tracy Davido, Radhika Gali, Peter Muscarella, Henny H. Billett
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 13, p 3712 (2024)
Background: Immune thrombocytopenia (ITP) is an acquired autoimmune disorder affecting patients of all ages and backgrounds. While current standards favor medical therapy in the frontline setting, splenectomy remains an integral part of treatment in
Externí odkaz:
https://doaj.org/article/a554bceb042f4a8d805d9ffa18fdc71d
Publikováno v:
Blood Advances. 7:224-226
Publikováno v:
Advances in Oncology. 1:85-95
Autor:
Mendel Goldfinger, Kith Pradhan, Michelly Abreu, Jesus D. Gonzalez-Lugo, Abdul-Hamid Bazarbachi, Lauren C. Shapiro, Margaret McCort, Balazs Halmos, Astha Thakkar, Kira Gritsman, Amit Verma, Aditi Shastri, Radhika Gali, R. Alejandro Sica, Noah Kornblum, Karen Fehn, Ira Braunschweig, Shafia Rahman, Ioannis Mantzaris, Lizamarie Bachier-Rodriguez
Publikováno v:
Leukemialymphoma. 63(10)
It is well established that COVID-19 carries a higher risk of morbidity and mortality in patients with hematologic malignancies, however, very little data on ethnicity specific responses in this particular patient population currently exist. We estab
Publikováno v:
Journal of Clinical Oncology. 40:e15610-e15610
e15610 Background: COVID 19 infection has worse outcomes and is more severe among frail patients and with co-morbidities. Additionally, it was suggested by Mehta et al that gastrointestinal malignancies may have worse outcomes. Based off these findin
Survival analysis of patients with early and standard onset colorectal cancer: A single center study
Autor:
Dhruv Patel, Catarina Martins Maia, Michael Lyudmer, Seda Tolu, Adel Chergui, Riya Jayesh Patel, So Yeon Kim, Radhika Gali, Ana Acuna Villaorduna, Sanjay Goel
Publikováno v:
Journal of Clinical Oncology. 40:e15512-e15512
e15512 Background: While more aggressive clinical/pathological features have been consistently described in between patients with early-onset (EO) and standard-onset (SO) colorectal cancer (CRC), survival data have been conflicting. While some studie
Autor:
Della F. Makower, Lucia Wolgast, Radhika Gali, Astha Thakkar, Shafia Rahman, Joseph A. Sparano, Noah Kornblum, Kith Pradhan, Benjamin A. Gartrell, Niyati Goradia, Margaret E McCort, Jesus Gonzalez Lugo, Sanjay Goel, Lizamarie Bachier-Rodriguez, R. Alejandro Sica, Amit Verma, Y. Goldstein, Roman Perez-Soler, Balazs Halmos, Lauren C. Shapiro, Brian Ko, So Yeon Kim, Stuart Packer
As COVID-19 has been shown to adversely affect patients with cancer, prophylactic strategies are critically needed. We determined the immunogenicity of COVID-19 vaccination in a cohort of cancer patients that had received full dosing with one of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::04313cf38c5b45b5d73e842d19474af9
https://doi.org/10.1101/2021.05.07.21256824
https://doi.org/10.1101/2021.05.07.21256824
Autor:
Radhika Gali, Damon E. Houghton, Mahua Dasgupta, Michael Jaglal, Manila Gaddh, Henny H. Billett, Pippa Simpson, Mingen Feng, Thein Hlaing Oo, Tzu-Fei Wang, Michael B. Streiff, Oluwatomiloba Onadeko, Lisa Baumann Kreuziger, Gemlyn George
Publikováno v:
Blood Adv
Standard treatment of catheter-associated upper extremity deep vein thrombosis (UE-DVT) is anticoagulation, although catheters are often removed for this indication. The optimal time for catheter removal and whether the act and/or timing of catheter
Autor:
Michael Jaglal, Manila Gaddh, Tzu-Fei Wang, Damon E. Houghton, Pippa Simpson, Henny H. Billett, Lisa Baumann Kreuziger, Radhika Gali, Gemlyn George, Oluwatomiloba Onadeko, Mingen Feng, Thein Hlaing Oo, Michael B. Streiff
Publikováno v:
Thrombosis research. 202
Introduction Optimal treatment of catheter-related thrombosis (CRT) is uncertain in patients with hematologic malignancy. We aimed to evaluate the treatment strategies, outcomes, and predictors of recurrent venous thromboembolism (VTE) associated wit
Autor:
Emma Rabinovich, Kith Pradhan, Helen Tracy Davido, Radhika Gali, Iffath Islam, Peter Muscarella, Henny H. Billett
Publikováno v:
Blood. 138:3161-3161
Background: Immune thrombocytopenia (ITP) is an acquired immune-mediated disorder characterized by frequent relapses. Splenectomy was considered an integral part of ITP therapy until the inception of newer agents, namely rituximab and thrombopoietin